These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 8658076)

  • 1. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
    Bulik CC; Sobel JD; Nailor MD
    Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.